Translated title of the contribution | : Daratumumab, a novel therapeutic human CD38 monoclonal antibody, effectively induces killing of multiple myeloma and other hematological tumors |
de Weers, M.,
Bakker, J. M.,
Vink, T.,
Jacobs, D. C. H.,
Oomen, L. A.,
Bleeker, W. K.,
van de Winkel, J. G. J.,
Parren, P. W. H. I.,
Tai, Y-T.,
Anderson, K. C.,
Peipp, M.,
Valerius, T.,
Slootstra, J. W. &
Lokhorst, H. M.,
2010,
p. 24-24.
1 p.Research output: Contribution to conference › Abstract › Other research output